Delivery Order SPE2DB22D9316-SPE2DB24FYN18
Award Date 1/10/24
Potential Completion Date 2/1/24
Potential Value $14K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $17,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of 68 mg NEXPLANON contraceptive implants. This delivery order falls under a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of pharmaceutical and medical supplies to military treatment facilities worldwide. The contract has no...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 68 mg NEXPLANON contraceptive implants. The $12,864.42 contract has a completion date of March 1, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $4,999,999 through 2025, to deliver a broad range...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 68 mg Nexplanon contraceptive implants. The contract, valued at $14,293.80, has a completion date of June 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999, awarded to DMS Pharmaceutical Group by DLA under the SPE2DB program. The IDC allows DLA to issue delivery orders for...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS. The award has a potential value of $21,440.70 and a completion date of February 8, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that supplies a wide range of pharmaceuticals and medical products to support military treatment facilities worldwide under various DLA contracts and indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS. The contract has a potential value of $3,573.45 and a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles (IDVs) with DLA to supply a variety of pharmaceuticals and medical products to military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,858.76 contract is for the delivery of 68 mg NEXPLANON contraceptive implants to support the medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's broader indefinite delivery contract SPE2DB24FA5HG with DLA, valued up to $4,999,999 through 2025, which enables...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $4,288.14 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,564,134,203 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This order was placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with the DLA, valued at up to $4,999,999 through 2025. The DLA utilizes this vehicle to issue delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed-price delivery order worth $3,573.45 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NEXPLANON 68 MG IMPLANTS. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the DLA, valued up to $4,999,999 through 2025, which enables the agency to order a broad range of pharmaceutical products to support military health...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 68 mg NEXPLANON contraceptive implants. The potential value of this award is $7,146.90 with a completion date of February 21, 2024. DMS Pharmaceutical Group holds a separate $4,999,999 indefinite delivery contract with DLA for a broad range of pharmaceutical items to support military health facilities worldwide.
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS. The $3,573.45 contract has a completion date of February 13, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products in support of military treatment facilities worldwide. This delivery order is...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB24FYN18Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 68 mg NEXPLANON contraceptive implants. The $14,293.80 order has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple DLA contracts and indefinite delivery vehicles to supply a variety of medical items and pharmaceuticals to military treatment facilities worldwide. This delivery order is issued against one of DMS Pharmaceutical Group's existing DLA contracts to provide necessary pharmaceutical and medical supplies on a recurring basis to support the operations of military healthcare centers globally.
Generated 4/10/24, 9:34 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 1/10/24 |